EX-23.1 3 tm2521171d2_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of NextCure, Inc. for the registration of 338,636 shares of its common stock and to the incorporation by reference therein of our report dated March 6, 2025, with respect to the financial statements of NextCure, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.

 

  /s/ Ernst & Young LLP
   
Baltimore, Maryland  

July 18, 2025